Upcoming IPO could net $700 million for China's Sihuan Pharmaceutical
This article was originally published in PharmAsia News
Executive Summary
China drug producer Sihuan Pharmaceutical Holdings Group Ltd. hopes its initial public offering will raise as much as $700 million